Testing PG-033 in healthy adults: a first-in-human study
Part of Skin clinical trials.
This trial tests a single dose of a new medicine called PG-033 in healthy adults. It checks how the drug moves through the body and how food affects it, to find the safest starting dose for future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- You are in good general health, with no chronic or serious medical conditions.
- You have not taken any prescription or over-the-counter medications (including supplements) in the last 2 weeks.
- You do not smoke more than 5 cigarettes a day, and you can avoid smoking during the study.
- You are willing to use effective birth control or avoid pregnancy for 3 months after the study ends.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new experimental drug called PG-033 in healthy adults. It helps doctors find out if the drug is safe and how your body processes it at different dose levels.
This study tests a new drug (BG-A3004) for safety in healthy volunteers and people with certain skin conditions like alopecia areata, cutaneous lichen planus, or vitiligo. It helps find out if the drug is safe and how the body processes it.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This study tests a new medicine called LH-001 in healthy volunteers to see if it is safe. You will receive either the medicine or a placebo (a dummy pill) and stay overnight for monitoring.
This study tests a new investigational drug called ISH0613 in healthy volunteers to see if it is safe and how the body processes it. It is the first time this drug is given to humans.
Hear when a new Lichen Simplex Chronicus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.